Science Explorer Back to mapMap
Discussion
Company · Troy · United States

Visca (United States)

Research works
6
▲ 139% vs 2018-21
Citations
27
4.6 per fractional work
Top-10% rate
12.8%
all institutions 10.0%
Open access
50%
world 40%
International
84%
world 18%

Not ranked overall: Visca (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Visca (United States) work in?

In all years, 96% of research at Visca (United States) is in Health Sciences, 3% in Life Sciences. Its largest fields are Medicine (92%), Health Professions (4%), Biochemistry, Genetics and Molecular Biology (2%). It does 2.0× the world's share of Health Sciences.

Health Sciences: 6 fractional works · 96.3% of its workMedicine: 5 fractional works · 92.2% of its workEndocrinology, Diabetes and Metabolism: 2 fractional works · 25.7% of its workOncology: 1 fractional works · 22.6% of its workPulmonary and Respiratory Medicine: 1 fractional works · 17.0% of its workPsychiatry and Mental health: 1 fractional works · 10.9% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 4.8% of its workEpidemiology: 0 fractional works · 2.9% of its workOtorhinolaryngology: 0 fractional works · 2.9% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 2.9% of its workSurgery: 0 fractional works · 2.6% of its workHealth Professions: 0 fractional works · 4.1% of its workGeneral Health Professions: 0 fractional works · 3.1% of its workPharmacy: 0 fractional works · 1.2% of its workLife Sciences: 0 fractional works · 3.2% of its workBiochemistry, Genetics and Molecular Biology: 0 fractional works · 2.0% of its workGenetics: 0 fractional works · 2.0% of its workNeuroscience: 0 fractional works · 1.2% of its workCognitive Neuroscience: 0 fractional works · 0.5% of its workNeurology: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.2% of its workSocial Sciences: 0 fractional works · 0.5% of its workPsychology: 0 fractional works · 0.5% of its workClinical Psychology: 0 fractional works · 0.5% of its workALL ITS WORKVisca (UnitedStates)6fractional works, all years
Life Sciences3%Health Sciences96%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 5 fields, with their numbers
    1. Medicine592.2%
    2. Health Professions04.1%
    1. Biochemistry, Genetics and Molecular Biology02.0%
    2. Neuroscience01.2%
    1. Psychology00.5%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What are the most cited papers from Visca (United States)?

The most cited paper from Visca (United States) is "Long-Term Versus Short-Term Clopidogrel Therapy in Patients Undergoing Coronary Stenting (from the Randomized Argentine Clopidogrel Stent [RACS] Trial)" (Víctor Bernardi, Jorge Szarfer, Gabriel Summay et al., 2006), with 31 citations. Next come "Prognostic impact of second primary tumors in head and neck cancer" (21) and "Unstable Thoracolumbar Injuries: Factors Affecting the Decision for Short-Segment vs Long-Segment Posterior Fixation" (11).

Most cited papers
#PaperReleasedCitations
1 Long-Term Versus Short-Term Clopidogrel Therapy in Patients Undergoing Coronary Stenting (from the Randomized Argentine Clopidogrel Stent [RACS] Trial) Víctor Bernardi, Jorge Szarfer, Gabriel Summay et al. · The American Journal of Cardiology 2 Dec 2006 31
2 Prognostic impact of second primary tumors in head and neck cancer Marta S. Patrucco, Marina V. Aramendi · European Archives of Oto-Rhino-Laryngology 28 Jun 2015 21
3 Unstable Thoracolumbar Injuries: Factors Affecting the Decision for Short-Segment vs Long-Segment Posterior Fixation Juan Pablo Cabrera, Alfredo J. Guiroy, Charles André Carazzo et al. · The International Journal of Spine Surgery Open access 17 Aug 2022 11
4 Estimación de la Incidencia de Cáncer de Tiroides en Capital Federal y el Gran Buenos Aires (período 2003-2011) Eduardo Néstor Faure, María Jimena Soutelo, Gabriel Faraj et al. · CONICET Digital (CONICET) Open access Mar 2012 11
5 Eventos cardiovasculares en una población cerrada. Seguimiento a 10 años Jorge E. Tartaglione, Gonzalo Grazioli, Marcelo Sarmiento et al. · Revista Argentina de Cardiología Open access 6 Jan 2026 4
All 14 most cited papers, with filters and sorting

Which research topics does Visca (United States) publish most on?

By volume in 2022-now: PARP inhibition in cancer therapy, Chronic Obstructive Pulmonary Disease (COPD) Research, Pleural and Pulmonary Diseases and Health and Lifestyle Studies.

  1. 1 PARP inhibition in cancer therapy Oncology 1 works
  2. 2 Chronic Obstructive Pulmonary Disease (COPD) Research Pulmonary and Respiratory Medicine 0 works
  3. 3 Pleural and Pulmonary Diseases Pulmonary and Respiratory Medicine 0 works
  4. 4 Health and Lifestyle Studies General Health Professions 0 works
  5. 5 Respiratory Support and Mechanisms Pulmonary and Respiratory Medicine 0 works
  6. 6 Aortic Disease and Treatment Approaches Pulmonary and Respiratory Medicine 0 works
  7. 7 Cardiac, Anesthesia and Surgical Outcomes Cardiology and Cardiovascular Medicine 0 works
  8. 8 Diabetes, Cardiovascular Risks, and Lipoproteins Endocrinology, Diabetes and Metabolism 0 works
  9. 9 Diabetes Management and Research Endocrinology, Diabetes and Metabolism 0 works
  10. 10 Nursing care and research Pharmacy 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available50.4%not open49.6%

World: 40% of research is openly available.

with international co-authors84.1%domestic only15.9%

World: 18% is written across borders.

How has Visca (United States)'s research output changed?

Output in 2022-2025 was 139% higher than in 2018-2021.

still counting2010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Visca (United States) as a percentage of every work published that year, 0.0000093% in 2023.

0.000020%0.000040%Visca (United States)0.000018% in 202420102020

Fractional works of Visca (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Troy

All research institutions in Troy

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Visca (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.